Global leadership Moria is a long-standing France-based leader in ophthalmic surgical instruments, including microkeratomes and corneal surgery tools, with a global footprint through offices in the US, China, and Japan. This positions them as a potential partner for international distributors and hospitals seeking premium ophthalmic instruments.

Strategic investment Recent minority stake acquisition by Eurazeo signals financial backing and growth potential, suggesting opportunities for scaled partnerships, co-development, or strategic collaborations to expand product reach and distribution channels.

Acquisition momentum Moria’s acquisition activity, including Sunstone Circuits, indicates a growth-oriented mindset and potential for expanded product lines or integrated solutions that could open bundled selling opportunities for ophthalmic centers and eye banks.

Cost-conscious market With revenue estimated between $1M and $10M and a competitive landscape that includes large players like Alcon and Bausch & Lomb, there are opportunities to position value-focused offerings, maintenance contracts, and training services to capture mid-market hospitals and clinics.

Sales enablement Strong relationships with leading corneal surgeons and eye banks imply demand for training, certifications, and service support; a proactive approach offering turnkey service agreements, consumables, and after-sales support could unlock recurring revenue streams.